FDA Approved: BUMETANIDE — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for Bumetanide submitted by Sagent Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Hepatic Cirrhosis
• Nephrotic Syndrome

Drugs mentioned

• BUMETANIDE (bumetanide)

Snippet

SUPPL AP for BUMETANIDE (BUMETANIDE)